Search research articles
Contact Us
Filters
Showing results (71-80 of 152) with videos related to
Page
of 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer
Karen L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Cancer
|
July 22, 2014
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
Philip A Philip, Bryan Goldman, Ramesh K Ramanathan, et al.
Cancer
|
July 22, 2014
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)
Cornelia M Ulrich, Cathryn Rankin, Adetunji T Toriola, et al.
Investigational New Drugs
|
October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
Lori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Oncology Reports
|
June 6, 2007
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization
Abbas Agaimy, Antje-Friederike Pelz, Christopher L Corless, et al.
Annals of Surgical Oncology
|
December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132
Dian Wang, Qiang Zhang, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Joseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2006
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127
Tomislav Dragovich, Sheryl McCoy, Cecilia M Fenoglio-Preiser, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 152) with videos related to
Sort By:
Page
of 16
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer
Karen L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Cancer
|
July 22, 2014
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
Philip A Philip, Bryan Goldman, Ramesh K Ramanathan, et al.
Cancer
|
July 22, 2014
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)
Cornelia M Ulrich, Cathryn Rankin, Adetunji T Toriola, et al.
Investigational New Drugs
|
October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
Lori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Oncology Reports
|
June 6, 2007
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization
Abbas Agaimy, Antje-Friederike Pelz, Christopher L Corless, et al.
Annals of Surgical Oncology
|
December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132
Dian Wang, Qiang Zhang, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Joseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2006
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127
Tomislav Dragovich, Sheryl McCoy, Cecilia M Fenoglio-Preiser, et al.
Page
of 16